Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis

por Dos Santos, Gael, Shende, Vishvesh, Damaso, Silvia, Yeakey, Anne
Publicado 2019

Passive enhanced safety surveillance of GSK’s quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza se...

por Dos Santos, Gaël, Yeakey, Anne, Shende, Vishvesh, Smith, Katie, Lin, Frederic, Zandman-van-Dijk, Elvira, Damaso, Silvia, Schmidt, Alexander
Publicado 2019

Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card

por de Lusignan, Simon, Ferreira, Filipa, Damaso, Silvia, Byford, Rachel, Pathirannehelage, Sameera, Yeakey, Anne, Yonova, Ivelina, Schuind, Anne, Dos Santos, Gael
Publicado 2019

367. Safety and Immunogenicity of a 50-μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Adolescents

por Figueroa, Amparo, Ali, Kashif, Berman, Gary, Zhou, Honghong, Deng, Weiping, Patel, Monali, Girard, Bethany, Yeakey, Anne, Slobod, Karen, Priddy, Frances, Miller, Jacqueline, Das, Rituparna
Publicado 2023

Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season

por Dos Santos, Gael, Nguyen, Bach-Yen, Damaso, Silvia, Godderis, Lode, Martínez-Gómez, Xavier, Eckermann, Tamara, Loos, Hugo, Salamanca de la Cueva, Ignacio, Shende, Vishvesh, Schmidt, Alexander C., Yeakey, Anne
Publicado 2019